Literature DB >> 6812527

Biosynthesis of vitamin B12. Different pathways in some aerobic and anaerobic microorganisms.

V Höllriegl, L Lamm, J Rowold, J Hörig, P Renz.   

Abstract

Radioactivity from [1'-14C]riboflavin was incorporated into the 5,6-dimethylbenzimidazole moiety of Vitamin B12 in the aerobes Bacillus megaterium, Nocardia rugosa and Streptomyces sp. as well as in the aerotolerant anaerobe Propionibacterium freudenreichii, but not in the anaerobe Eubacterium limosum. As recently published for E. limosum, also in the anaerobe Clostridium barkeri radioactivity from [1-14C]glycine and [2-14C]glycine was found in the 5,6-dimethylbenzimidazole moiety, but not in the corrin moiety. The addition of L-[methyl-14C]methionine to C. barkeri led to the labeling of the corrin moiety and the 5,6-dimethylbenzimidazole moiety, showing that the seven "extra" methyl groups in the corrin ring as well as the two methyl groups of the base part originate from this precursor. In Clostridium thermoaceticum, forming the vitamin B12 analog 5-methoxybenzimidazolylcobamide, [1-14C]glycine and [2-14C]glycine were also incorporated into the 5-methoxybenzimidazole moiety, but not into the corrin ring. In E. limosum L-[U-14C]glutamate led to the labeling of the corrin ring of vitamin B12, but not of its base moiety. These results together with data from the literature indicate that a common biosynthetic pathway might exist for the corrinoid biosynthesis in aerobic microorganisms, and in those aerotolerant anaerobes like the Propionibacteria, which form the 5,6-dimethylbenzimidazole moiety of vitamin B12 only under aerobic conditions. They also show that this pathway differs from the pathway found in anaerobic bacteria.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6812527     DOI: 10.1007/bf00508722

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.552


  17 in total

1.  Biosynthesis of 5, 6-dimethylbenzimidazole from riboflavin Transformation of C-1' of riboflavin into C-2 of 5, 6-dimethylbenzimidazole.

Authors:  P Renz; R Weyhenmeyer
Journal:  FEBS Lett       Date:  1972-04-15       Impact factor: 4.124

2.  Isolation and structure of a new factor of the vitamin B12 group: guanosine diphosphate factor B.

Authors:  R BARCHIELLI; G BORETTI; A DI MARCO; P JULITA; A MIGLIACCI; A MINGHETTI; C SPALLA
Journal:  Biochem J       Date:  1960-02       Impact factor: 3.857

3.  Clostridium barkeri sp. n.

Authors:  E R Stadtman; T C Stadtman; I Pastan; L D Smith
Journal:  J Bacteriol       Date:  1972-05       Impact factor: 3.490

4.  Biosynthesis of delta-Aminolevulinic Acid from Glutamate in Agmenellum quadruplicatum.

Authors:  J A Kipe-Nolt; S E Stevens
Journal:  Plant Physiol       Date:  1980-01       Impact factor: 8.340

5.  Formation of delta-aminolevulinic acid from glutamic acid by a partially purified enzymes system from wheat leaves.

Authors:  S H Ford; H C Friedmann
Journal:  Biochim Biophys Acta       Date:  1979-08-15

6.  Concurrent decrease of enzymic activities concerned with the synthesis of coenzyme B 12 and of propionic acid in propionibacteria.

Authors:  I A Menon; D Shemin
Journal:  Arch Biochem Biophys       Date:  1967-08       Impact factor: 4.013

7.  On the biosynthesis of 5-methoxybenzimidazole. Precursor-function of 5-hydroxybenzimidazole, benzimidazole and riboflavin.

Authors:  R Wurm; R Weyhenmeyer; P Renz
Journal:  Eur J Biochem       Date:  1975-08-15

8.  Biosynthesis of vitamin B12. Experiments with the anaerobe Eubacterium limosum and some labelled substrates.

Authors:  L Lamm; J A Hörig; P Renz; G Heckmann
Journal:  Eur J Biochem       Date:  1980-08

9.  The synthesis and properties of 4,5-dioxovaleric acid, a possible intermediate in the biosynthesis of 5-aminolaevulinic acid, and its in vivo formation in Scenedesmus obliquus.

Authors:  D Dörnemann; H Senger
Journal:  Biochim Biophys Acta       Date:  1980-02-21

10.  INCORPORATION OF C14 FROM CARBON DIOXIDE INTO SUGAR PHOSPHATES, CARBOXYLIC ACIDS, AND AMINO ACIDS BY CLOSTRIDIUM THERMOACETICUM.

Authors:  L LJUNGDAHL; H G WOOD
Journal:  J Bacteriol       Date:  1965-04       Impact factor: 3.490

View more
  8 in total

1.  Finding the final pieces of the vitamin B12 biosynthetic jigsaw.

Authors:  Martin J Warren
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

2.  Pseudo-B12 joins the cofactor family.

Authors:  Michiko E Taga; Graham C Walker
Journal:  J Bacteriol       Date:  2007-12-14       Impact factor: 3.490

3.  Formation of the chlorophyll precursor delta-aminolevulinic acid in cyanobacteria requires aminoacylation of a tRNAGlu species.

Authors:  G P O'Neill; D M Peterson; A Schön; M W Chen; D Söll
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

4.  The CobII and CobIII regions of the cobalamin (vitamin B12) biosynthetic operon of Salmonella typhimurium.

Authors:  J C Escalante-Semerena; M G Johnson; J R Roth
Journal:  J Bacteriol       Date:  1992-01       Impact factor: 3.490

5.  Regulation of cobalamin biosynthetic operons in Salmonella typhimurium.

Authors:  J C Escalante-Semerena; J R Roth
Journal:  J Bacteriol       Date:  1987-05       Impact factor: 3.490

6.  Single-enzyme conversion of FMNH2 to 5,6-dimethylbenzimidazole, the lower ligand of B12.

Authors:  Michael J Gray; Jorge C Escalante-Semerena
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-14       Impact factor: 11.205

7.  Anaerobic biosynthesis of the lower ligand of vitamin B12.

Authors:  Amrita B Hazra; Andrew W Han; Angad P Mehta; Kenny C Mok; Vadim Osadchiy; Tadhg P Begley; Michiko E Taga
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-05       Impact factor: 11.205

8.  Bacillus megaterium has both a functional BluB protein required for DMB synthesis and a related flavoprotein that forms a stable radical species.

Authors:  Hannah F Collins; Rebekka Biedendieck; Helen K Leech; Michael Gray; Jorge C Escalante-Semerena; Kirsty J McLean; Andrew W Munro; Stephen E J Rigby; Martin J Warren; Andrew D Lawrence
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.